【摘要】 目的：探讨性激素疗法联合比索洛尔治疗围绝经期功能性心律失常的临床效果。方法：选取2021年1月—2022年10月抚州市妇幼保健院的80例围绝经期功能性心律失常患者，按照治疗方法的不同将其分为性激素治疗组和联合组，每组40例，性激素治疗组予以小剂量雌激素替代治疗，联合组在性激素治疗组的基础上口服比索洛尔。比较两组治疗效果、心功能指标及心率变异性(HRV)、雌二醇(E₂)和卵泡刺激素(FSH)等指标变化。结果：联合组的临床总有效率明显高于性激素治疗组，差异有统计学意义(P2均较治疗前显著上升，且联合组高于性激素治疗组，差异均有统计学意义(P2) and follicle stimulating hormone (FSH) were compared between the two groups. Result： The total clinical effective rate of the combination group was significantly higher than that of the sex hormone treatment group， the difference was statistically significant (P2in the two groups were significantly higher than those before treatment， and the combination group was higher than the sex hormone treatment group， the differences were statistically significant (P[1]。绝大部分围绝经期的女性心律失常为生理性 ......